The numbers of CTC-positive in patients with sarcoma and total CTCs in pediatric sarcomas are similar to data previously reported at diagnosis in carcinomas [152], with progressive disease and poor outcome in patients with the highest EpCAM levels [141]. This evidence concerns the gene EPCAM and sarcoma.